QRCS, Vodafone team up to support needy patients at Rumailah
July 13 2019 10:34 PM
Some of the equipment procured as part of the initiative.
Some of the equipment procured as part of the initiative

Under its Patient Support Fund, Qatar Red Crescent Society (QRCS) has launched a charity project to support long-stay patients, older persons and persons with special needs at Rumailah Hospital.
With funding from Vodafone Qatar, QRCS has procured 10 physiotherapy equipment for Rumailah Hospital to create a medical and physical rehabilitation room with a capacity of 60 patients per month.
These supplies "will have a significant role in enhancing the morale of the patients, as well as facilitate the healing process, both in terms of effectiveness and duration", QRCS has said in a statement.

Another equipment

Najat A al-Haidous, head of Social Care at QRCS, said long-stay and permanent-stay patients at Rumailah Hospital suffered joint stiffness and bedsores because of spending a lot of time in bed without being able to exercise or do any sort of activity.
Al-Haidous stressed the importance of sports for both patients and healthy persons. “The purpose of this project is to boost the patients’ self-confidence, attitude and energy. This will help them overcome the stress of being at hospital for a long time, accelerate the treatment and regain their fitness,” she noted
She thanked Vodafone Qatar for contributing to this charity project and urged all institutions and individuals in Qatar to support patients and medical facilities by donating to the QRCS Patient Support Fund.
Mohamed al-Yafei, head of Public Sector at Vodafone Qatar, added: “Vodafone Qatar is proud of its long-term partnership with QRCS, which has resulted in many charitable projects. This partnership is part of our corporate social responsibility programme, which covers a wide range of initiatives, inspired by our commitment towards the local community. 
"We believe in the importance of creating a healthy society as key to the advancement of nations”.

There are no comments.

LEAVE A COMMENT Your email address will not be published. Required fields are marked*